Inversion sure is the right word for the Allergan/Pfizer deal. Because what got the colonists lathered up enough to fight a war against the one global super power at the time was taxation without representation.
Somehow that idea got turned on its head, and now one of the largest drug companies in America wants the representation the United States has to offer without the commensurate taxation (all this, mind you, from a voter registered as Republican).
From a shareholder perspective, it’s easy to connect the dots. Lower taxes means higher earnings, and higher earnings means a higher stock price, and presto, shareholder value has been increased. What else would anyone expect the senior leadership and board to do?